Relay runs away with $400M series C on back of protein conformation platform

Protein motion company Relay Therapeutics Inc. (Cambridge, Mass.) raised $400 million in an untranched series C led by new investor SoftBank Vision Fund. Relay President and CEO Sanjiv Patel told BioCentury the round will provide multiple years of runway and allow Relay to move several of its lead compounds into first-in-human

Read the full 515 word article

User Sign In